Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The Oracle Health Sciences' Clinical One platform has been selected by Servier to make its vision of a next-generation clinical trial management environment a reality. To start and manage clinical trials is a lengthy and regulated process that ...
read more
Servier announced the launch of InnoPreP, a new preparative chromatography service offered under its contract development and manufacturing business.
read more
Servier has finalized the previously announced acquisition of Shire's oncology branch after obtaining regulatory clearance.
read more
Servier has entered into a collaborative study with Harvard University researchers to explore a new avenue for the treatment of type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).
read more
Servier CDMO announced the company has invested $7.5 million in intensified technology including continuous chromatography with SMB and SFC with solvent recycling of up to 90% to lower environmental impact.
read more
Servier and Miragen Therapeutics announced they have extended their research collaboration through September 2019.
read more
Wednesday, January 08, 2020
Pfenex announced that Serum Institute achieved WHO prequalification for Pneumosil, a 10-valent pneumococcal conjugate vaccine.
read more
SeraNovo has signed a second License Agreement with Carna Biosciences.
read more
Monday, September 09, 2024
Serán BioScience, LLC announced that it has completed an expansion to increase the number of process manufacturing suites at its facility in Bend, Oregon, from 6 to 14, adding approximately 130% more CGMP clinical manufacturing capacity.
read more
Wednesday, October 22, 2025
Serán BioScience has announced an expansion of its commercial manufacturing footprint with the development of a new 100,000-square-foot campus in Bend, Oregon.
read more
Tuesday, September 17, 2024
Serán Bioscience announced a strategic growth transaction of more than $200 million. Bain Capital Life Sciences led the transaction, while existing investor Vivo Capital remains a key shareholder in the company.
read more
Serán Bioscience’s announced that their state-of-the-art, large-scale spray dryer is now fully operational and is being used to support late-stage clinical drug product portfolios. The SD-720 spray drying system was custom designed and built by Serán...
read more
SeraCare Life Sciences, a global life sciences company providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics, today announced that Charlie Mamrak joined the company as CEO ...
read more
Thursday, January 31, 2019
seqWell and Gencove announced a partnership for seqWell's plexWell library preparation and Gencove's imputation and analysis software to provide a solution for low-pass whole genome sequencing.
read more
Thursday, October 07, 2021
Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced that the Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness ...
read more